Glofitamab,Obinutuzumab,Tocilizumab
roche
['mantle,(-dismantle)', 'obinu', 'glofitamab', 'lymphoma', 'lymsm']
glofitamab/obinutuzumab regimen produces early, durable responses in relapsed/refractory mantle cell lymphoma #lymsm #ash22 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.